Kymera Therapeutics to Participate in Upcoming December Investor Conferences

Rhea-AI Summary

Kymera Therapeutics (NASDAQ: KYMR) will participate in three investor fireside chats in early December 2025: Piper Sandler 37th Annual Healthcare Conference in New York on Dec 2 at 2:30 p.m. ET, Citi 2025 Global Healthcare Conference in Miami on Dec 3 at 11:15 a.m. ET, and Evercore 8th Annual Healthcare Conference in Coral Gables on Dec 4 at 8:45 a.m. ET. Live webcasts and archived replays will be available in the Investors "News and Events" section at www.kymeratx.com.

WATERTOWN, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events: 

• Piper Sandler 37^th Annual Healthcare Conference in New York, NY on December 2 at 2:30 p.m. ET;
• Citi 2025 Global Healthcare Conference in Miami, FL on December 3 at 11:15 a.m. ET; and
• Evercore 8^th Annual Healthcare Conference in Coral Gables, FL on December 4 at 8:45 a.m. ET.
  

Live webcasts of the presentations will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. Replays of the webcasts will be archived and available following the events. 

About Kymera Therapeutics 
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X or LinkedIn. 

Investor and Media Contact:  
  
Justine Koenigsberg 
Vice President, Investor Relations 
investors@kymeratx.com 
media@kymeratx.com  
857-285-5300  

FAQ

When will Kymera Therapeutics (KYMR) present at the Piper Sandler 37th Annual Healthcare Conference?

Kymera will present at Piper Sandler on December 2, 2025 at 2:30 p.m. ET.

How can investors watch Kymera Therapeutics (KYMR) presentations from the December 2025 conferences?

Live webcasts and archived replays will be available under News and Events in the Investors section at www.kymeratx.com.

What time is Kymera Therapeutics (KYMR) scheduled to present at the Citi 2025 Global Healthcare Conference?

Kymera is scheduled for December 3, 2025 at 11:15 a.m. ET at the Citi conference in Miami.

When is Kymera Therapeutics (KYMR) speaking at the Evercore 8th Annual Healthcare Conference?

Kymera will speak at Evercore on December 4, 2025 at 8:45 a.m. ET in Coral Gables.

Will Kymera Therapeutics (KYMR) make webcasts available after the December 2025 investor events?

Yes. Replays of each webcast will be archived and available following the events on the company website.

Which investor events will Kymera Therapeutics (KYMR) attend in early December 2025?

Kymera will attend Piper Sandler (Dec 2), Citi 2025 (Dec 3), and Evercore (Dec 4) investor conferences.